Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-unitsXiaona Hu, Xiaofeng Yu, Yiqin Huang et al.|BMC Gastroenterology|2012Cited by 113
The anti-inflamm-aging and hepatoprotective effects of huperzine A in d-galactose-treated ratsQingwei Ruan, Zhuowei Yu, Fang Liu et al.|Mechanisms of Ageing and Development|2013Cited by 65
Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trialFangyuan Dong, Zhijun Bao, Yan Zhang et al.|Scientific Reports|2016Cited by 60
The Neurovascular Protective Effects of Huperzine A on D-Galactose-Induced Inflammatory Damage in the Rat HippocampusQingwei Ruan, Zhuowei Yu, Xiaona Hu et al.|Gerontology|2014Cited by 51
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease modelDongmei Shi, Zhijun Bao, Jianfeng Yao et al.|Lipids in Health and Disease|2014Cited by 44